Trump Announces TrumpRx Expansion, Adding 160 More Drugs

President Trump on Friday announced that over 100 prescription medications would be added to his administration’s direct-to-consumer drug platform, TrumpRx, the second expansion of the initiative in as many months. “I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” ...

Read More

Skyrocketing GLP-1 Demand Creates Major Financial Strain For Employers

GLP-1 drugs are a double-edged sword for the nation’s employers. Although they are having a demonstrable effect on workplace health, the high cost is putting a strain on their budgets. GLP-1s, known by brand names such as Ozempic, Wegovy, Mounjaro or Zepbound, originally were developed to help regulate blood sugar in people with Type 2 ...

Read More

Judge Throws Out Policy Imposing $100,000 Fees for Skilled Worker Visas

A Trump administration initiative to impose $100,000 fees on employers seeking visas for skilled foreign workers amounts to an unlawful tax on those companies and must be voided “in its entirety,” a federal judge ruled on Monday. The decision by Judge Leo T. Sorokin of the Federal District Court for the District of Massachusetts nullified ...

Read More

Upcoming Billing Change Could Make Pregnancy Pricier

Having a baby in the United States is about to get more complicated. Under new billing codes that take effect in January, doctors who manage maternity care will start charging à la carte for visits and services related to pregnancy, childbirth, and postpartum care. It’s an about-face from recent years, when doctors have often received ...

Read More

Supreme Court Backs Generic Drug Maker In ‘Skinny Label’ Patent Case

The U.S. Supreme Court handed down a unanimous ruling Thursday that could help increase the number of generic drugs available in the United States. The court ruled in favor of Hikma Pharmaceuticals, a company that wants to sell a generic version of Vascepa, a brand-name drug from Amarin Pharmaceuticals, using a “skinny label” government drug approval label. ...

Read More

2M Children Have Dropped Out Of Medicaid, CHIP Since January 2025

There are 2 million fewer children enrolled in either Medicaid or the Children’s Health Insurance Program compared to January 2025, according to a new report. The Children and Families at Georgetown University’s McCourt School of Public Policy operates a state-by-state enrollment tracker that identified the declines through April, and warned that enrollment drop-offs at this scale should ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square